Metabolic
Retatrutide
From $30.00
Triple GIP/GLP-1/glucagon agonist. Next-gen metabolic peptide.
Select Size
In stock — ships within 1–2 business days after payment
Details
Retatrutide is a next-generation triple agonist targeting GIP, GLP-1, and glucagon receptors, studied in metabolic research for multi-receptor incretin signalling and energy-balance models. Lab-verified and lyophilized for in vitro research use only.
⚠ For research use only. Not for human or veterinary use. Sold for in vitro laboratory research and development purposes only.
